サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1722774

デング熱検査市場レポート：検査タイプ、エンドユーザー、地域別、2025年～2033年

Dengue Testing Market Report by Test Type (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, and Others), End User (Hospitals, Diagnostic Centers, and Others), and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 144 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
デング熱検査市場レポート：検査タイプ、エンドユーザー、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

デング熱検査の世界市場規模は2024年に6億1,080万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに9億1,170万米ドルに達し、2025年から2033年にかけて4.32%の成長率（CAGR）を示すと予測しています。同市場は主に、世界のデング熱流行の増加、診断技術の進歩、公衆衛生意識の高まり、世界各地の流行地域における政府の取り組みや資金援助によって牽引されています。

デング熱は、感染したネッタイシマカに刺されることで広がるウイルス感染症です。関節や筋肉の痛み、高熱、腹痛、嘔吐、呼吸困難、しめった冷たい皮膚、頭痛、目の奥の痛み、疲労感、発疹、鼻や歯茎の軽い出血などを引き起こします。デング熱は、酵素結合免疫吸着測定法（ELISA）、RT-PCR、デング熱IgG/IgM迅速検査などのデング熱検査によって診断されます。デング熱検査は、デングウイルスの異なる血清型を同定するために、血液サンプルを用いて医療専門家によって実施されます。

デング熱検査の市場動向：

世界の温暖化と蚊の繁殖地の増加によるデング熱患者の増加は、市場を牽引する主な要因の一つです。さらに、デング熱の正確で効率的な診断は、臨床治療において極めて重要な役割を果たしています。デング熱の正確かつ効率的な診断は、臨床医療において極めて重要な役割を担っており、病態解明、臨床試験、アウトブレイク対策、学術研究、ワクチン開発、サーベイランス活動、重症例の早期発見、症例確認、その他の感染症との鑑別診断などに役立っています。これらの利点は、世界中のデング熱検査の需要にプラスの影響を与えています。これに加えて、世界の人口密集地は生活環境が劣悪なため、病気にかかりやすいです。これは、公衆意識の欠如による劣悪な衛生環境と廃棄物管理技術とともに、市場の成長を刺激しています。さらに、ヘルスケア専門家は、自己防衛や殺虫剤の熱霧吹きによってデング熱を予防するよう人々に呼びかけています。これは、いくつかの国の政府によって組織された啓発キャンペーンと相まって、市場の成長を促進しています。その他の成長促進要因としては、急速な都市化とヘルスケア業界の技術進歩が挙げられます。さらに、主な市場参入企業は、高効率で費用対効果の高いデング熱検査キットを開発するため、研究開発（R&D）活動に幅広く投資しています。

本レポートで扱う主な質問

  • デング熱検査市場の規模は？
  • 2025年～2033年の世界のデング熱検査市場の予想成長率は？
  • デング熱検査の世界市場を牽引する主要因は？
  • デング熱検査の世界市場におけるCOVID-19の影響は？
  • デング熱検査の世界市場における検査タイプ別の区分は？
  • デング熱検査の世界市場におけるエンドユーザー別の区分は？
  • デング熱検査の世界市場における主要地域は？
  • デング熱検査の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のデング熱検査市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：検査タイプ別

  • ELISAベースの検査
  • RT-PCRベースの検査
  • デング熱IgG/IgM迅速検査
  • その他

第7章 市場内訳：エンドユーザー別

  • 病院
  • 診断センター
  • その他

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Abnova Corporation
    • CerTest Biotec S.L.
    • DiaSorin S.p.A.
    • F. Hoffmann-La Roche AG
    • InBios International Inc.
    • NovaTec Immundiagnostica GmbH
    • OriGene Technologies Inc.
    • PerkinElmer Inc.
    • Quest Diagnostics Incorporated
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Dengue Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Dengue Testing Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Dengue Testing Market: Breakup by Test Type (in %), 2024
  • Figure 5: Global: Dengue Testing Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Dengue Testing Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Dengue Testing (ELISA-based Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Dengue Testing (ELISA-based Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Dengue Testing (RT-PCR based Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Dengue Testing (RT-PCR based Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Dengue Testing (Dengue IgG/IgM Rapid Test) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Dengue Testing (Dengue IgG/IgM Rapid Test) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Dengue Testing (Other Test Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Dengue Testing (Other Test Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Dengue Testing (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Dengue Testing (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Dengue Testing (Diagnostic Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Dengue Testing (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Dengue Testing (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Dengue Testing (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: North America: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: North America: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: United States: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: United States: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Canada: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Canada: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Asia-Pacific: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Asia-Pacific: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: China: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: China: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Japan: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Japan: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: India: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: India: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: South Korea: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: South Korea: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Australia: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Australia: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Indonesia: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Indonesia: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Others: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Others: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Europe: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Europe: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Germany: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Germany: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: France: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: France: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: United Kingdom: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: United Kingdom: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Italy: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Italy: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Spain: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Spain: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Russia: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Russia: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Latin America: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Latin America: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Brazil: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Brazil: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Mexico: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Mexico: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Middle East and Africa: Dengue Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Middle East and Africa: Dengue Testing Market: Breakup by Country (in %), 2024
  • Figure 69: Middle East and Africa: Dengue Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Global: Dengue Testing Industry: SWOT Analysis
  • Figure 71: Global: Dengue Testing Industry: Value Chain Analysis
  • Figure 72: Global: Dengue Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Dengue Testing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Dengue Testing Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 3: Global: Dengue Testing Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 4: Global: Dengue Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Dengue Testing Market: Competitive Structure
  • Table 6: Global: Dengue Testing Market: Key Players
目次
Product Code: SR112025A5648

The global dengue testing market size reached USD 610.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 911.7 Million by 2033, exhibiting a growth rate (CAGR) of 4.32% during 2025-2033. The market is primarily driven by the increasing dengue fever prevalence worldwide, advancements in diagnostic technologies, rising public health awareness, and government initiatives and funding in endemic regions across the globe.

Dengue, also known as breakbone fever, is a viral infection that spreads through the bite of an infected Aedes aegypti mosquito. It causes ache in the joints and muscles, high fever, abdominal pain, vomiting, difficulty in breathing, clammy and cold skin, headache, pain behind the eyes, fatigue, rashes, and mild bleeding in the nose and gums. It is diagnosed via dengue testing, which includes enzyme-linked immunosorbent assay (ELISA), RT-PCR, and dengue IgG/IgM rapid tests. Dengue testing is performed by medical professionals using a blood sample to identify the different serotypes of the dengue virus.

Dengue Testing Market Trends:

The growing cases of dengue on account of the rising global warming and breeding sites of mosquitos across the globe represents one of the major factors driving the market. Moreover, accurate and efficient diagnosis of dengue plays a pivotal role in clinical care. It assists in pathogenesis, clinical trials, outbreak control, academic research, vaccine development, surveillance activities, early detection of severe cases, and case confirmation and differential diagnosis with other infectious diseases. These benefits are positively influencing the demand for dengue testing around the world. Besides this, densely populated areas worldwide are more disease-prone due to low living conditions. This, along with poor sanitation and waste management techniques due to lack of public awareness, is stimulating the growth of the market. In addition, healthcare professionals are encouraging people to prevent dengue by self-protection and thermal fogging of insecticides. This, coupled with awareness campaigns organized by the government of several countries, is propelling the growth of the market. Other growth-inducing factors are rapid urbanization and technological advancements in the healthcare industry. Furthermore, key market players are extensively investing in research and development (R&D) activities to develop highly efficient and cost-effective dengue test kits.

Key Market Segmentation:

Breakup by Test Type:

  • ELISA-based Tests
  • RT-PCR based Tests
  • Dengue IgG/IgM Rapid Test
  • Others

Breakup by End User:

  • Hospitals
  • Diagnostic Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Abnova Corporation, CerTest Biotec S.L., DiaSorin S.p.A., F. Hoffmann-La Roche AG, InBios International Inc., NovaTec Immundiagnostica GmbH, OriGene Technologies Inc., PerkinElmer Inc., Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.How big is the dengue testing market?
  • 2.What is the expected growth rate of the global dengue testing market during 2025-2033?
  • 3.What are the key factors driving the global dengue testing market?
  • 4.What has been the impact of COVID-19 on the global dengue testing market?
  • 5.What is the breakup of the global dengue testing market based on the test type?
  • 6.What is the breakup of the global dengue testing market based on the end user?
  • 7.What are the key regions in the global dengue testing market?
  • 8.Who are the key players/companies in the global dengue testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Dengue Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 ELISA-based Tests
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 RT-PCR based Tests
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dengue IgG/IgM Rapid Test
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Centers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Abnova Corporation
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
    • 13.3.3 CerTest Biotec S.L.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 DiaSorin S.p.A.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 InBios International Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 NovaTec Immundiagnostica GmbH
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 OriGene Technologies Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 PerkinElmer Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Quest Diagnostics Incorporated
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Thermo Fisher Scientific Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis